MedTrace Logo

Relationship Between Effect Duration of Rocuronium and Body Composition Analysis Data.

NCT05515835 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2023-01-04

No results posted yet for this study

Summary

The induction dose of rocuronium is typically decided based on the patient's body weight, but the effect duration of rocuronium is variable. Some studies suggest that body composition analysis data, such as skeletal muscle mass or total body water, may correlate better with the duration time of rocuronium. Therefore, we plan to analyse body composition in patients undergoing total intravenous general anesthesia, give the patients a fixed dose (50mg) of rocuronium, and check the correlation between duration time of rocuronium and body composition analysis data.

Conditions

  • Rocuronium
  • Body Composition

Interventions

DEVICE

body composition analysis

Patients will undergo body composition analysis using bioelectical impedance method before anesthesia.

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-05
Primary Completion
2022-12-30
Completion
2023-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05515835 on ClinicalTrials.gov